Hestia Insight Inc. (HSTA) Research
Hestia Insight Inc. delivers specialized strategic consulting and capital market advisory support, primarily catering to small to mid-sized businesses within the healthcare, biotech, and fintech sectors. The company's service portfolio also extends to healthcare management and patient-focused solutions. Moreover, Hestia Insight Inc. is involved in creating and analyzing healthcare technologies, specifically those related to neurological and psychiatric conditions. Completing its range of services, the firm provides management and assistance for medical supply sales, alongside comprehensive sales and marketing strategy and guidance. Formerly known as Luxshmi Investments, Inc., the company officially rebranded to Hestia Insight Inc. in May 2019. It operates from its headquarters in Las Vegas, Nevada.
Market snapshot
- Symbol
- HSTA
- Price
- $0.04
- Day change
- 0.00%
- Market cap
- $1.1M
- P/E ratio
- -1.94x
- 52-week range
- 0.0205-0.25
- Sector
- Technology
- Industry
- Software - Application
Peer companies
Open Hestia Insight Inc. (HSTA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.